Sai Life Sciences Ltd Share Price
As on 19 November 2025 at 01:31 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
0.92%
Over 6 Months
17.46%
Over 1 Year
15.07%
Over 3 Years
None%
Sai Life Sciences Ltd Summary
Close ₹879.85
Open ₹877
High ₹904.70
Low ₹874.70
Volume 3,92,438
Net Turnover (in Cr) ₹34.89
52Wk High ₹943
52Wk Low ₹636.10
52Wk High / Low
636.10
943
Sai Life Sciences Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹18,491.96
EPS (TTM) 13.43
Book Value (BV) 109.59
Div. Yield -
P/E (TTM) 65.53
Price/Book Value 8.03
Delivery % 47.05 %
Face Value 1
Key Ratios
PE Ratio 91.60
PB Ratio 7.33
EV to Sales 9.57
PEG Ratio -1.08
ROA 7
ROE 10.92
Debt-Equity 0.36
Net Profit Margin 10.56
Operating Profit Margin 26.17
Sai Life Sciences Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,731.35 | 1,494.27 | 1,245.11 | 897.74 | 787.18 |
| Total Expenses | 1,503.65 | 1,385.04 | 1,228.70 | 888.05 | 705.26 |
| Profit Before Tax | 227.70 | 109.23 | 16.41 | 9.70 | 81.92 |
| Profit After Tax | 170.13 | 82.81 | 9.99 | 6.23 | 61.10 |
| Operating Profit After Depreciation | 303.87 | 195.14 | 93.47 | 60.57 | 112.24 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,488.21 | 1,179.84 | 1,036.92 | 750.95 | 753.42 |
| Total Non Current Assets | 1,655.46 | 1,330.02 | 1,222.70 | 1,213.14 | 1,013.81 |
| Total Current Assets | 1,504.51 | 945.11 | 963.95 | 944.20 | 803.61 |
| Total Assets | 3,159.97 | 2,275.14 | 2,186.65 | 2,157.35 | 1,817.42 |
| Total Shareholder's Fund | 2,128.35 | 975.14 | 888.09 | 878.57 | 862.95 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 314.05 | 263.09 | 219.40 | 104.87 | -36.38 |
| Net Cash Used In Investing Activities | -536.39 | -191.35 | -99 | -101.64 | -259.89 |
| Net Cash Used In Financing Activities | 301.43 | -95.30 | -200.65 | 71.92 | 295.50 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,679.38 | 1,448.01 | 1,185.36 | 869.17 | 778.76 |
| Total Expenses | 1,447.67 | 1,319.01 | 1,152.68 | 846.82 | 691.18 |
| Profit Before Tax | 231.72 | 129 | 32.69 | 22.35 | 87.58 |
| Profit After Tax | 173.46 | 95.23 | 24.24 | 15.68 | 65.30 |
| Operating Profit After Depreciation | 301.75 | 208.73 | 103.33 | 69.84 | 116.92 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,377.51 | 1,073.75 | 922.59 | 857.59 | 702.44 |
| Total Non Current Assets | 1,642.12 | 1,288.75 | 1,178.69 | 1,162.23 | 1,024.63 |
| Total Current Assets | 1,494.54 | 951.17 | 951.93 | 943.66 | 791.86 |
| Total Assets | 3,136.66 | 2,239.92 | 2,130.62 | 2,105.89 | 1,816.49 |
| Total Shareholder's Fund | 2,167.46 | 1,011.20 | 912.73 | 891.04 | 867.52 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 330.35 | 250.64 | 221.47 | 88.38 | -25.94 |
| Net Cash Used In Investing Activities | -564.71 | -190.05 | -111.23 | -94.63 | -279.46 |
| Net Cash Used In Financing Activities | 314.31 | -84.63 | -190.04 | 80.95 | 303.58 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 537.47 | 496.42 | 579.51 | 439.78 | 395.56 |
| Total Expenses | 391.64 | 375.49 | 421.93 | 320.03 | 293.34 |
| Profit Before Tax | 112.06 | 80.75 | 118.80 | 71.65 | 55.32 |
| Profit After Tax | 83.84 | 60.46 | 88.27 | 53.85 | 41.51 |
| Operating Profit after Depreciation | 161.16 | 130.83 | 167.18 | 128.87 | 112.17 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 526.67 | 483.04 | 567.01 | 428.60 | 381.97 |
| Total Expenses | 386.82 | 370.04 | 413.10 | 317.41 | 281.20 |
| Profit Before Tax | 110.87 | 77.98 | 120.47 | 67.91 | 58.49 |
| Profit After Tax | 82.95 | 58.37 | 89.94 | 51.06 | 43.85 |
| Operating Profit after Depreciation | 154.78 | 123.01 | 163.73 | 120.64 | 110.72 |
Sai Life Sciences Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 868.13
S2 856.42
S3 838.13
Pivot 886.42
R1 898.13
R2 916.42
R3 928.13
Moving Average
20 SMA 895.48
50 SMA 881.44
100 SMA 852.93
200 SMA 784.35
Sai Life Sciences Ltd Corporate Actions
No available data
Sai Life Sciences Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Sai Life Sciences Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| DSP Healthcare Fund | 5.23% |
| Invesco India Smallcap Fund | 5.20% |
| Invesco India Large & Mid Cap Fund | 4.35% |
| Invesco India Midcap Fund | 3.30% |
| Nippon India Pharma Fund | 2.81% |
Sai Life Sciences Ltd News
Sai Life Sciences to conduct board meeting
On 6 November 2025
25 Oct 2025, 11:29 am
Sai Life Sciences launches integrated CMC services
In partnership with Agility Life Sciences and Centrix Pharma Solutions
08 Oct 2025, 01:46 pm
Sai Life Sciences allots 1.50 lakh equity shares under ESOP
19 Sep 2025, 07:50 pm
Sai Life Sciences commissions phase II of its production block in Bidar (Unit IV)
Total installed reactor capacity expands to 700KL at Bidar
28 Aug 2025, 03:43 pm
Sai Life Sciences slips as block deal sparks talk of TPG Asia exit
Sai Life Sciences dropped 5.08% to Rs 860.50 following heavy block deal activity on the exchanges.
26 Aug 2025, 02:38 pm
Sai Life Sciences Ltd Stock Analysis
- Annual revenue for Sai Life Sciences Ltd increased by 15.98% to ₹1,679.38 crore in FY 2025 from ₹1,448.01 crore in FY 2024.
- Annual Net Profit for Sai Life Sciences Ltd increased by 82.15% to ₹173.46 crore in FY 2025 from ₹95.23 crore in FY 2024.
- Promoter Shareholding in Sai Life Sciences Ltd decreased by 0.61% in the most recent quarter, from 35.15% in June 2025 to 34.93% in September 2025.
- Sai Life Sciences Ltd delivered a 1-year return of 15.07% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Sai Life Sciences Ltd share price moved down by 1.22% from its previous close of INR ₹879.85. The latest Sai Life Sciences Ltd share price is INR ₹869.10.
- Sai Life Sciences Ltd share price today has been at a low of 862.95 and a high of 879.85. Over the past 52 weeks, the Sai Life Sciences Ltd share price has seen a low of 636.10 and a high of 943.
FAQ’s
What is the share price of Sai Life Sciences Ltd today?
Sai Life Sciences Ltd share price as on 18 Nov 2025 is ₹ 869.1
What is the Market Cap of Sai Life Sciences Ltd?
The market cap of Sai Life Sciences Ltd stock is ₹18,491.96 Cr.
What is the PE Ratio of Sai Life Sciences Ltd?
The Price to Earnings (P/E) Ratio of Sai Life Sciences Ltd is 91.60
What is the PB Ratio of Sai Life Sciences Ltd?
The Price to Book (P/B) Ratio of Sai Life Sciences Ltd is 7.33
What is the 52 week high of Sai Life Sciences Ltd Share Price?
The 52 week high of Sai Life Sciences Ltd share price stands at ₹943
What is the 52 week low of Sai Life Sciences Ltd Share Price?
The 52 week low of Sai Life Sciences Ltd share price stands at ₹636.10
How can I buy shares of Sai Life Sciences Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Sai Life Sciences Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
